{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:28Z","timestamp":1793826028860,"version":"4.6.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1186\/s13613-025-01464-w","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T21:07:00Z","timestamp":1747775220000},"page":"67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Critical insights for intensivists on Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-196X","authenticated-orcid":false,"given":"Nicolas","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Marois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Le Guennec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rohaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Demeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1186\/s13613-025-01464-w_bb0010","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"issue":"10045","key":"10.1186\/s13613-025-01464-w_bb0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/WNL.54.1.33","article-title":"Physiologic-pathologic correlation in Guillain-Barr\u00e9 syndrome in children","volume":"54","author":"Lu","year":"2000","journal-title":"Neurology"},{"key":"10.1186\/s13613-025-01464-w_bb0030","unstructured":"Guillain G, Barr\u00e9 J, Strohl A. Sur Un syndromede radiculo-n\u00e9vrite avec hyperalbuminose du Liquide C\u00e9phalorachidien Sans r\u00e9action cellulaire. Remarques Sur les caract\u00e8res cliniques et graphiques des r\u00e9flexes tendineux. Bull et Mem de la Soc M\u00e9d des Hop de Paris. 1916;1462\u201370."},{"issue":"12","key":"10.1186\/s13613-025-01464-w_bb0035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","article-title":"Guillain-Barr\u00e9 syndrome: a century of progress","volume":"12","author":"Goodfellow","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0040","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.24442","article-title":"Innate immunity to Campylobacter jejuni in Guillain-Barr\u00e9 syndrome","volume":"78","author":"Huizinga","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0950268898001861","article-title":"The risk of Guillain-Barr\u00e9 syndrome following infection with Campylobacter jejuni","volume":"122","author":"McCarthy","year":"1999","journal-title":"Epidemiol Infect"},{"issue":"Pt 10","key":"10.1186\/s13613-025-01464-w_bb0060","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/123.10.2171","article-title":"Haemophilus influenzae infection and Guillain-Barr\u00e9 syndrome","volume":"123","author":"Mori","year":"2000","journal-title":"Brain"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/aje\/kwr072","article-title":"Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without Circulating A\/H1N1 viruses","volume":"174","author":"Grimaldi-Bensouda","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barr\u00e9 syndrome associated with preceding hepatitis E virus infection","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology"},{"issue":"10027","key":"10.1186\/s13613-025-01464-w_bb0075","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0080","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/cid\/ciz625","article-title":"Chikungunya, a risk factor for Guillain-Barr\u00e9 syndrome","volume":"70","author":"Stegmann-Planchard","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-025-01464-w_bb0085","doi-asserted-by":"crossref","unstructured":"Frontera JA, Tamborska AA, Doheim MF, Garcia-Azorin D, Gezegen H, Guekht A et al. Neurological Events Reported after COVID-19 Vaccines: An Analysis of VAERS. Ann Neurol. 2022.","DOI":"10.1002\/ana.26339"},{"issue":"10","key":"10.1186\/s13613-025-01464-w_bb0090","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamaneurol.2017.1912","article-title":"Neurological complications associated with Anti-Programmed death 1 (PD-1) antibodies","volume":"74","author":"Kao","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0095","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1634\/theoncologist.2019-0255","article-title":"Guillain-Barr\u00e9 syndrome during Platinum-Based chemotherapy: A case series and review of the literature","volume":"25","author":"Pappa","year":"2020","journal-title":"Oncologist"},{"issue":"13","key":"10.1186\/s13613-025-01464-w_bb0100","doi-asserted-by":"crossref","first-page":"e1220","DOI":"10.1212\/WNL.0000000000006246","article-title":"Surgery and risk of Guillain-Barr\u00e9 syndrome: A French nationwide epidemiologic study","volume":"91","author":"Rudant","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes as new target antigens in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Kaida","year":"2004","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1186\/s13613-025-01464-w_bb0110","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","article-title":"Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis","volume":"40","author":"Yuki","year":"1990","journal-title":"Neurology"},{"issue":"8","key":"10.1186\/s13613-025-01464-w_bb0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mus.880150806","article-title":"Severe acute axonal form of Guillain-Barr\u00e9 syndrome associated with IgG anti-GD1a antibodies","volume":"15","author":"Yuki","year":"1992","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1186\/s13613-025-01464-w_bb0120","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","article-title":"A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure","volume":"178","author":"Yuki","year":"1993","journal-title":"J Exp Med"},{"issue":"21","key":"10.1186\/s13613-025-01464-w_bb0125","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","article-title":"Anti-Gal-C antibodies in GBS subsequent to Mycoplasma infection: evidence of molecular mimicry","volume":"57","author":"Kusunoki","year":"2001","journal-title":"Neurology"},{"issue":"Pt 9","key":"10.1186\/s13613-025-01464-w_bb0135","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barr\u00e9 syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0140","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cells10040844","article-title":"Macrophages and autoantibodies in demyelinating diseases","volume":"10","author":"Koike","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1186\/s13613-025-01464-w_bb0145","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"issue":"10","key":"10.1186\/s13613-025-01464-w_bb0150","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.clinph.2004.05.009","article-title":"Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy","volume":"115","author":"Vucic","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases","volume":"17","author":"Cutillo","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jns5.12074","article-title":"Genetics of Guillain-Barr\u00e9 syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions","volume":"19","author":"Blum","year":"2014","journal-title":"J Peripher Nerv Syst"},{"issue":"9","key":"10.1186\/s13613-025-01464-w_bb0165","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/01.WNL.0000143055.09646.31","article-title":"The occurrence of Guillain-Barre syndrome within families","volume":"63","author":"Geleijns","year":"2004","journal-title":"Neurology"},{"key":"10.1186\/s13613-025-01464-w_bb0170","doi-asserted-by":"crossref","first-page":"577651","DOI":"10.1016\/j.jneuroim.2021.577651","article-title":"Genetic basis of Guillain-Barre syndrome","volume":"358","author":"Khanmohammadi","year":"2021","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0175","doi-asserted-by":"crossref","first-page":"e952","DOI":"10.1212\/NXI.0000000000000952","article-title":"Guillain-Barr\u00e9 syndrome outbreak in Peru 2019 associated with Campylobacter jejuni infection","volume":"8","author":"Ramos","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1186\/s13613-025-01464-w_bb0180","unstructured":"Guillain-Barr\u00e9 outbreak in Peru. Available from: https:\/\/www.who.int\/fr\/emergencies\/disease-outbreak-news\/item\/2023-DON477 (accessed August 8, 2024)."},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.1990.00530010104027","article-title":"Acute relapsing Guillain-Barr\u00e9 syndrome after long asymptomatic intervals","volume":"47","author":"Wijdicks","year":"1990","journal-title":"Arch Neurol"},{"issue":"Pt 4","key":"10.1186\/s13613-025-01464-w_bb0190","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/115.4.1093","article-title":"Recurrent Guillain-Barr\u00e9 syndrome. Clinical and laboratory features","volume":"115","author":"Grand\u2019Maison","year":"1992","journal-title":"Brain"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/CND.0000000000000464","article-title":"Aggressive acquired demyelinating neuropathy caused by NF-155: initially Treatment-Resistant","volume":"25","author":"Jamall","year":"2023","journal-title":"J Clin Neuromuscul Dis"},{"issue":"5","key":"10.1186\/s13613-025-01464-w_bb0200","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/brain\/awac418","article-title":"Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage","volume":"146","author":"Appeltshauser","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0210","doi-asserted-by":"crossref","first-page":"e209725","DOI":"10.1212\/WNL.0000000000209725","article-title":"Antibodies in autoimmune neuropathies: what to test, how to test, why to test","volume":"103","author":"Pascual-Go\u00f1i","year":"2024","journal-title":"Neurology"},{"issue":"12","key":"10.1186\/s13613-025-01464-w_bb0215","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn","year":"2023","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1186\/s13613-025-01464-w_bb0220","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barre syndrome","volume":"83","author":"Rajabally","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0225","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/jns.12087","article-title":"Post-traumatic stress symptoms in Guillain-Barr\u00e9 syndrome patients after prolonged mechanical ventilation in ICU: a preliminary report","volume":"19","author":"Le Guennec","year":"2014","journal-title":"J Peripher Nerv Syst"},{"issue":"17","key":"10.1186\/s13613-025-01464-w_bb0230","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","article-title":"The Guillain-Barr\u00e9 syndrome","volume":"326","author":"Ropper","year":"1992","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1186\/s13613-025-01464-w_bb0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0240","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.wnl.0000167549.09664.b8","article-title":"Distinguishing acute-onset CIDP from Guillain-Barr\u00e9 syndrome with treatment related fluctuations","volume":"65","author":"Ruts","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0245","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10286-018-0542-y","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update","volume":"29","author":"Zaeem","year":"2019","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","article-title":"Dysautonomia in Guillain-Barr\u00e9 syndrome: prevalence, clinical spectrum, and outcomes","volume":"32","author":"Chakraborty","year":"2020","journal-title":"Neurocrit Care"},{"issue":"16","key":"10.1186\/s13613-025-01464-w_bb0255","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain-Barre syndrome: a long-term follow-up study","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0040-1715480","article-title":"Severe Locked-In-Like Guillain-Barr\u00e9\u2019s syndrome: dilemmas in diagnosis and treatment","volume":"52","author":"Korinthenberg","year":"2021","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropsychologia.2011.12.015","article-title":"Event related potentials elicited by violations of auditory regularities in patients with impaired consciousness","volume":"50","author":"Faugeras","year":"2012","journal-title":"Neuropsychologia"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0270","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00415-011-6330-4","article-title":"Guillain-Barr\u00e9 syndrome associated with normal or exaggerated tendon reflexes","volume":"259","author":"Yuki","year":"2012","journal-title":"J Neurol"},{"issue":"11","key":"10.1186\/s13613-025-01464-w_bb0275","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/jnnp-2013-304993","article-title":"Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia","volume":"84","author":"Wakerley","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1186\/s13613-025-01464-w_bb0280","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrneurol.2015.115","article-title":"Polyneuritis cranialis\u2013subtype of Guillain-Barr\u00e9 syndrome?","volume":"11","author":"Wakerley","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0285","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mus.24887","article-title":"Isolated facial diplegia in Guillain-Barr\u00e9 syndrome: bifacial weakness with paresthesias","volume":"52","author":"Wakerley","year":"2015","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2013-305397","article-title":"Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome","volume":"85","author":"Wakerley","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0295","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.25242","article-title":"Paraparetic Guillain-Barr\u00e9 syndrome: nondemyelinating reversible conduction failure restricted to the lower limbs","volume":"55","author":"Kimachi","year":"2017","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1186\/s13613-025-01464-w_bb0300","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain-Barr\u00e9 and miller fisher syndromes\u2013new diagnostic classification","volume":"10","author":"GBS Classification Group, GBS Classification Group","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0305","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/practneurol-2014-000937","article-title":"Mimics and chameleons in Guillain-Barr\u00e9 and miller fisher syndromes","volume":"15","author":"Wakerley","year":"2015","journal-title":"Pract Neurol"},{"issue":"7","key":"10.1186\/s13613-025-01464-w_bb0310","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jnnp-2012-304655","article-title":"Is \u2018bickerstaff brainstem encephalitis\u2019 really encephalitis?","volume":"84","author":"Kuwabara","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0315","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ana.410030628","volume":"3","author":"Criteria for diagnosis of Guillain-Barr\u00e9 syndrome","year":"1978","journal-title":"Ann Neurol"},{"key":"10.1186\/s13613-025-01464-w_bb0320","doi-asserted-by":"crossref","unstructured":"Asbury AK, Cornblath DR, Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990;27Suppl:S21\u201324.","DOI":"10.1002\/ana.410270707"},{"issue":"5","key":"10.1186\/s13613-025-01464-w_bb0325","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 syndrome trial group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1186\/s13613-025-01464-w_bb0330","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clinph.2021.12.014","article-title":"Electrodiagnosis of Guillain-Barre syndrome in the international GBS outcome study: differences in methods and reference values","volume":"138","author":"Arends","year":"2022","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1186\/s13613-025-01464-w_bb0340","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1111\/ene.15998","article-title":"How to distinguish Guillain-Barr\u00e9 syndrome from nitrous oxide-induced neuropathy: A 2-year, multicentric, retrospective study","volume":"30","author":"Fortanier","year":"2023","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0345","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1007\/s00415-024-12264-w","article-title":"Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the greater Paris area","volume":"271","author":"Dawudi","year":"2024","journal-title":"J Neurol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0350","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.clinph.2015.06.032","article-title":"Ultrasound and electrophysiologic findings in patients with Guillain-Barr\u00e9 syndrome at disease onset and over a period of six months","volume":"127","author":"Grimm","year":"2016","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0355","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.clinph.2015.06.030","article-title":"Serial peripheral nerve ultrasound in Guillain-Barr\u00e9 syndrome","volume":"127","author":"Razali","year":"2016","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-020-01737-0","article-title":"Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Altmann","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1186\/s13613-025-01464-w_bb0365","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Aguilar L, Camps-Renom P, Lleix\u00e0 C, Pascual-Go\u00f1i E, D\u00edaz-Manera J, Rojas-Garc\u00eda R et al. Serum neurofilament light chain predicts long-term prognosis in Guillain-Barr\u00e9 syndrome patients. J Neurol Neurosurg Psychiatry. 2020;jnnp-2020-323899.","DOI":"10.1101\/2020.03.24.20042200"},{"key":"10.1186\/s13613-025-01464-w_bb0370","doi-asserted-by":"crossref","unstructured":"Jacobs BC. Neurofilament light chain as biomarker for axonal damage in Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry. 2020;jnnp-2020-324308.","DOI":"10.1136\/jnnp-2020-324308"},{"issue":"11","key":"10.1186\/s13613-025-01464-w_bb0375","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s004150050506","article-title":"Indicators of Dysautonomia in severe Guillain-Barr\u00e9 syndrome","volume":"246","author":"Pfeiffer","year":"1999","journal-title":"J Neurol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0380","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-510X(91)90303-O","article-title":"Clinical signs in severe Guillain-Barr\u00e9 syndrome: analysis of 63 patients","volume":"104","author":"de Jager","year":"1991","journal-title":"J Neurol Sci"},{"issue":"1129","key":"10.1186\/s13613-025-01464-w_bb0385","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/postgradmedj-2019-136870","article-title":"Renal salt wasting in Guillain-Barr\u00e9 syndrome","volume":"95","author":"Kumar","year":"2019","journal-title":"Postgrad Med J"},{"key":"10.1186\/s13613-025-01464-w_bb0390","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archinte.1965.03870010115014","volume":"116","author":"WITH THE GUILLAIN-BARR\u2019E SYNDROME","year":"1965","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1186\/s13613-025-01464-w_bb0395","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/jnnp.2009.192369","article-title":"Renal salt wasting as part of Dysautonomia in Guillain-Barre syndrome","volume":"82","author":"Lenhard","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 11","key":"10.1186\/s13613-025-01464-w_bb0400","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/brain\/awh585","article-title":"Vivid Dreams, hallucinations, psychosis and REM sleep in Guillain-Barr\u00e9 syndrome","volume":"128","author":"Cochen","year":"2005","journal-title":"Brain"},{"key":"10.1186\/s13613-025-01464-w_bb0405","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-025-01464-w_bb0410","doi-asserted-by":"crossref","unstructured":"Hughes RAC, Swan AV, van Doorn PA. Intravenous Immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014;(9):CD002063.","DOI":"10.1002\/14651858.CD002063.pub6"},{"key":"10.1186\/s13613-025-01464-w_bb0415","first-page":"CD001446","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0420","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"The French cooperative group on plasma exchange in Guillain-Barr\u00e9 syndrome","volume":"41","author":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome","year":"1997","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1186\/s13613-025-01464-w_bb0425","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00003246-199305000-00006","article-title":"Plasma exchange morbidity in Guillain-Barr\u00e9 syndrome: results from the French prospective, randomized, multicenter study. The French cooperative group","volume":"21","author":"Bouget","year":"1993","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0430","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered Immunoglobulin in the treatment of childhood Guillain-Barr\u00e9 syndrome: a randomized trial","volume":"116","author":"Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0435","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1474-4422(20)30494-4","article-title":"Second intravenous Immunoglobulin dose in patients with Guillain-Barr\u00e9 syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial","volume":"20","author":"Walgaard","year":"2021","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0440","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0000000000000581","article-title":"Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis","volume":"83","author":"Willison","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0445","first-page":"e57066","article-title":"Treatment efficacy of plasmapheresis versus intravenous Immunoglobulin in Guillain-Barr\u00e9 syndrome management: A systematic review","volume":"16","author":"Savithri Nandeesha","year":"2024","journal-title":"Cureus"},{"issue":"9047","key":"10.1186\/s13613-025-01464-w_bb0450","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Plasma exchange, intravenous Immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 syndrome trial group","volume":"349","author":"Randomised trial of","year":"1997","journal-title":"Lancet"},{"issue":"11","key":"10.1186\/s13613-025-01464-w_bb0455","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/jnnp.54.11.957","article-title":"Treatment related fluctuations in Guillain-Barr\u00e9 syndrome after high-dose Immunoglobulins or plasma-exchange","volume":"54","author":"Kleyweg","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0460","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archneur.58.6.893","article-title":"Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Lawn","year":"2001","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0465","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcrc.2013.10.026","article-title":"Simple bedside predictors of mechanical ventilation in patients with Guillain-Barre syndrome","volume":"29","author":"Kannan Kanikannan","year":"2014","journal-title":"J Crit Care"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0470","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5694\/mja17.00552","article-title":"Predictors of respiratory failure in patients with Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"208","author":"Green","year":"2018","journal-title":"Med J Aust"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0475","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-020-00742-z","article-title":"Early mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome at high risk of respiratory failure: a randomized trial","volume":"10","author":"Melone","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0480","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00003246-200301000-00044","article-title":"French cooperative group on plasma exchange in Guillain-Barr\u00e9 syndrome. Early predictors of mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0485","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome","volume":"67","author":"Walgaard","year":"2010","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0490","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp-2022-329937","article-title":"Modified Erasmus GBS respiratory insufficiency score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"94","author":"Luijten","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0495","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.26312","article-title":"International validation of the Erasmus Guillain-Barr\u00e9 syndrome respiratory insufficiency score","volume":"91","author":"Doets","year":"2022","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1186\/s13613-025-01464-w_bb0500","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1474-4422(06)70603-2","article-title":"Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a prospective study","volume":"5","author":"Durand","year":"2006","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0505","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1385\/NCC:1:4:415","article-title":"Respiratory dysfunction in Guillain-Barr\u00e9 syndrome","volume":"1","author":"Orlikowski","year":"2004","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0510","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/ajrccm\/144.4.814","article-title":"Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barr\u00e9 syndrome","volume":"144","author":"Chevrolet","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1186\/s13613-025-01464-w_bb0515","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jocn.2020.01.032","article-title":"Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barr\u00e9 syndrome","volume":"72","author":"Kalita","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0520","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/cc10043","article-title":"A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome","volume":"15","author":"Fourrier","year":"2011","journal-title":"Crit Care"},{"issue":"8","key":"10.1186\/s13613-025-01464-w_bb0525","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1058::AID-MUS8>3.0.CO;2-G","article-title":"Tracheostomy in Guillain-Barr\u00e9 syndrome","volume":"22","author":"Lawn","year":"1999","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1186\/s13613-025-01464-w_bb0530","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/mus.26377","article-title":"Intubation, tracheostomy, and decannulation in patients with Guillain-Barr\u00e9-syndrome-does dysphagia matter?","volume":"59","author":"Schr\u00f6der","year":"2019","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0535","doi-asserted-by":"crossref","first-page":"e16090","DOI":"10.1111\/ene.16090","article-title":"Predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a 22 year cohort study from a single Italian centre","volume":"31","author":"Galassi","year":"2024","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0540","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/CPJ.0000000000000793","article-title":"Prolonged ventilatory support for patients recovering from Guillain-Barr\u00e9 syndrome","volume":"11","author":"Cheng","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0545","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1385\/NCC:5:3:230","article-title":"Factors predicting extubation success in patients with Guillain-Barr\u00e9 syndrome","volume":"5","author":"Nguyen","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1186\/s13613-025-01464-w_bb0550","doi-asserted-by":"crossref","unstructured":"Liu J, Wang LN, McNicol ED. Pharmacological treatment for pain in Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2015;4CD009950.","DOI":"10.1002\/14651858.CD009950.pub3"},{"issue":"6\u20137","key":"10.1186\/s13613-025-01464-w_bb0555","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neurol.2016.03.004","article-title":"Lidocaine-medicated plaster for treating acute autonomic and sensory neuropathy with erythromelalgia-like presentations","volume":"172","author":"Gales","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"10.1186\/s13613-025-01464-w_bb0560","first-page":"CD008630","article-title":"Pharmacological treatment other than corticosteroids, intravenous Immunoglobulin and plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"1","author":"Doets","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"Pt 5","key":"10.1186\/s13613-025-01464-w_bb0565","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0570","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jns.12194","article-title":"Inhibition of complement in Guillain-Barr\u00e9 syndrome: the ICA-GBS study","volume":"22","author":"Davidson","year":"2017","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"10.1186\/s13613-025-01464-w_bb0575","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of Eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0580","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12028-023-01707-3","article-title":"Guidelines for neuroprognostication in adults with Guillain-Barr\u00e9 syndrome","volume":"38","author":"Busl","year":"2023","journal-title":"Neurocrit Care"},{"issue":"7","key":"10.1186\/s13613-025-01464-w_bb0585","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/mus.880110714","article-title":"Prognostic value of electrodiagnosis in Guillain-Barr\u00e9 syndrome","volume":"11","author":"Miller","year":"1988","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0590","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.410230406","article-title":"Plasmapheresis and Guillain-Barr\u00e9 syndrome: analysis of prognostic factors and the effect of plasmapheresis","volume":"23","author":"McKhann","year":"1988","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1186\/s13613-025-01464-w_bb0595","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0600","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-016-0311-5","article-title":"Tracheostomy or not: prediction of prolonged mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"26","author":"Walgaard","year":"2017","journal-title":"Neurocrit Care"},{"issue":"7","key":"10.1186\/s13613-025-01464-w_bb0605","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1007\/s00415-024-12295-3","article-title":"Takotsubo cardiomyopathy in Guillain-Barr\u00e9 syndrome","volume":"271","author":"Terayama","year":"2024","journal-title":"J Neurol"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0610","doi-asserted-by":"crossref","first-page":"e000893","DOI":"10.1136\/bmjopen-2012-000893","article-title":"Relevance of anxiety in clinical practice of Guillain-Barre syndrome: a cohort study","volume":"2","author":"Sharshar","year":"2012","journal-title":"BMJ Open"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0615","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/CCM.0000000000003635","article-title":"Dysglycemia and neurologic outcome in mechanically ventilated patients with Guillain-Barr\u00e9 syndrome","volume":"47","author":"Polito","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-025-01464-w_bb0620","first-page":"507","article-title":"Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review","volume":"48","author":"Khan","year":"2012","journal-title":"Eur J Phys Rehabil Med"},{"issue":"4","key":"10.1186\/s13613-025-01464-w_bb0625","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3138\/ptc.2015-58","article-title":"Influence of exercise on patients with Guillain-Barr\u00e9 syndrome: A systematic review","volume":"68","author":"Simatos Arsenault","year":"2016","journal-title":"Physiother Can"},{"issue":"3","key":"10.1186\/s13613-025-01464-w_bb0630","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jns.12646","article-title":"Efficacy and safety of Eculizumab in Guillain-Barre syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial","volume":"29","author":"Kuwabara","year":"2024","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0635","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-020-00742-z","article-title":"Early mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome at high risk of respiratory failure: a randomized trial","volume":"10","author":"Melone","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"12","key":"10.1186\/s13613-025-01464-w_bb0640","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00134-006-0332-1","article-title":"Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barr\u00e9 syndrome","volume":"32","author":"Orlikowski","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01464-w_bb0645","doi-asserted-by":"crossref","unstructured":"Dhar R, Stitt L, Hahn AF. (2008) The morbidity and outcome of patients with Guillain-Barr\u00e9 syndrome admitted to the intensive care unit. J Neurol Sci 2008, 264:121\u2013128.","DOI":"10.1016\/j.jns.2007.08.005"},{"issue":"9","key":"10.1186\/s13613-025-01464-w_bb0650","doi-asserted-by":"crossref","first-page":"e047449","DOI":"10.1136\/bmjopen-2020-047449","article-title":"Weaning from mechanical ventilation in people with neuromuscular disease: a systematic review","volume":"11","author":"Bernardes Neto","year":"2021","journal-title":"BMJ Open"},{"key":"10.1186\/s13613-025-01464-w_bb0655","doi-asserted-by":"crossref","unstructured":"Orlikowski D, Prigent H, Rapha\u00ebl JC, Sharshar T. Acute respiratory failure in Guillain-Barr\u00e9 syndrome and myasthenia gravis. R\u00e9animation 2005 14(2):118\u2013125.","DOI":"10.1016\/j.reaurg.2004.10.016"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0660","doi-asserted-by":"crossref","first-page":"19523","DOI":"10.1038\/s41598-024-70373-y","article-title":"Weaning from mechanical ventilation during myasthenic crisis, a monocentric retrospective study","volume":"14","author":"Mazeraud","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0665","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13613-024-01290-6","article-title":"Spontaneous breathing trial with pressure support on positive end-expiratory pressure and extensive use of non-invasive ventilation versus T-piece in difficult-to-wean patients from mechanical ventilation: a randomized controlled trial","volume":"14","author":"Mezidi","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1186\/s13613-025-01464-w_bb0670","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13613-024-01396-x","article-title":"Comprehensive assessment and progression of health status during neurorehabilitation in survivors of critical illness: a prospective cohortstudy","volume":"14","author":"Egger","year":"2024","journal-title":"Ann Intensive Care"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-025-01464-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:08:39Z","timestamp":1776672519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2110582025000548"],"URL":"https:\/\/doi.org\/10.1186\/s13613-025-01464-w","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical insights for intensivists on Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-025-01464-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 The Author(s) 2025. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"67"}}